Author:
Ohta Masahiko,Murakami Nobuya,Kato Katsuaki,Mizota Masahiro,Miwa Ichitomo,Okuda Jun,Yoshimasa Yasunao,Kuzuya Hideshi,Nakao Kazuwa,Imura Hiroo
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference28 articles.
1. Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats;Kato;Eur J Pharmacol,1991
2. Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataracts in rats;Kato;Jpn J Pharmacol,1990
3. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil;Kato;Chem Pharm Bull (Tokyo),1991
4. Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats;Nakayama;Eur J Pharmacol,1995
5. Effect of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats;Nakayama;Eur J Pharmacol,1995
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献